Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levemir in ageing patients with type 2 diabetes
2006-006589-41Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Efficacy objectives at 4 months and 7 months. Started Mar 2007; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-006589-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006589-41.